Multicenter Analysis of Advanced Stage Grade 3A Follicular Lymphoma Outcomes by Frontline Treatment Regimen

Nirav N. Shah; Aniko Szabo; Raya Saba; Lauren Strelec; Dheeraj Kodali; John L. Vaughn; Olukemi Esan; David T. Yang; Anthony R. Mato; Abraham S. Kanate; Horatiu Olteanu; Mehdi Hamadani; Timothy S. Fenske; Vaishalee P. Kenkre; Jakub Svoboda; Amanda F. Cashen; Narendranath Epperla

doi:10.1016/j.clml.2018.11.010

Multicenter Analysis of Advanced Stage Grade 3A Follicular Lymphoma Outcomes by Frontline Treatment Regimen

Nirav N. Shah, Aniko Szabo, Raya Saba, Lauren Strelec, Dheeraj Kodali, John L. Vaughn, Olukemi Esan, David T. Yang, Anthony R. Mato, Abraham S. Kanate, Horatiu Olteanu, Mehdi Hamadani, Timothy S. Fenske, Vaishalee P. Kenkre, Jakub Svoboda, Amanda F. Cashen, Narendranath Epperla

Laboratory Medicine and Pathology

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

Grade 3A follicular lymphoma (FL) is a heterogenous disease with multiple frontline treatment regimens. We performed a multicenter retrospective analysis to evaluate the efficacy of various frontline regimens for grade 3A FL. Although anthracycline-based therapy was superior to the combination of chemotherapy with cyclophosphamide, vincristine, and prednisone for grade 3A FL, clinical outcomes, including survival, were similar compared to bendamustine-based treatment.

Original language	English (US)
Pages (from-to)	95-102
Number of pages	8
Journal	Clinical Lymphoma, Myeloma and Leukemia
Volume	19
Issue number	2
DOIs	https://doi.org/10.1016/j.clml.2018.11.010
State	Published - Feb 2019

Keywords

Chemotherapy
Non-Hodgkin lymphoma

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1016/j.clml.2018.11.010

Cite this

Shah, N. N., Szabo, A., Saba, R., Strelec, L., Kodali, D., Vaughn, J. L., Esan, O., Yang, D. T., Mato, A. R., Kanate, A. S., Olteanu, H., Hamadani, M., Fenske, T. S., Kenkre, V. P., Svoboda, J., Cashen, A. F., & Epperla, N. (2019). Multicenter Analysis of Advanced Stage Grade 3A Follicular Lymphoma Outcomes by Frontline Treatment Regimen. Clinical Lymphoma, Myeloma and Leukemia, 19(2), 95-102. https://doi.org/10.1016/j.clml.2018.11.010

Shah, NN, Szabo, A, Saba, R, Strelec, L, Kodali, D, Vaughn, JL, Esan, O, Yang, DT, Mato, AR, Kanate, AS, Olteanu, H, Hamadani, M, Fenske, TS, Kenkre, VP, Svoboda, J, Cashen, AF & Epperla, N 2019, 'Multicenter Analysis of Advanced Stage Grade 3A Follicular Lymphoma Outcomes by Frontline Treatment Regimen', Clinical Lymphoma, Myeloma and Leukemia, vol. 19, no. 2, pp. 95-102. https://doi.org/10.1016/j.clml.2018.11.010

@article{5b004f5c5b924fa58b3432f1a972d918,

title = "Multicenter Analysis of Advanced Stage Grade 3A Follicular Lymphoma Outcomes by Frontline Treatment Regimen",

abstract = "Grade 3A follicular lymphoma (FL) is a heterogenous disease with multiple frontline treatment regimens. We performed a multicenter retrospective analysis to evaluate the efficacy of various frontline regimens for grade 3A FL. Although anthracycline-based therapy was superior to the combination of chemotherapy with cyclophosphamide, vincristine, and prednisone for grade 3A FL, clinical outcomes, including survival, were similar compared to bendamustine-based treatment.",

keywords = "Chemotherapy, Non-Hodgkin lymphoma",

author = "Shah, {Nirav N.} and Aniko Szabo and Raya Saba and Lauren Strelec and Dheeraj Kodali and Vaughn, {John L.} and Olukemi Esan and Yang, {David T.} and Mato, {Anthony R.} and Kanate, {Abraham S.} and Horatiu Olteanu and Mehdi Hamadani and Fenske, {Timothy S.} and Kenkre, {Vaishalee P.} and Jakub Svoboda and Cashen, {Amanda F.} and Narendranath Epperla",

note = "Publisher Copyright: {\textcopyright} 2018 Elsevier Inc.",

year = "2019",

month = feb,

doi = "10.1016/j.clml.2018.11.010",

language = "English (US)",

volume = "19",

pages = "95--102",

journal = "Clinical Lymphoma, Myeloma and Leukemia",

issn = "2152-2650",

publisher = "Cancer Media Group",

number = "2",

}

TY - JOUR

T1 - Multicenter Analysis of Advanced Stage Grade 3A Follicular Lymphoma Outcomes by Frontline Treatment Regimen

AU - Shah, Nirav N.

AU - Szabo, Aniko

AU - Saba, Raya

AU - Strelec, Lauren

AU - Kodali, Dheeraj

AU - Vaughn, John L.

AU - Esan, Olukemi

AU - Yang, David T.

AU - Mato, Anthony R.

AU - Kanate, Abraham S.

AU - Olteanu, Horatiu

AU - Hamadani, Mehdi

AU - Fenske, Timothy S.

AU - Kenkre, Vaishalee P.

AU - Svoboda, Jakub

AU - Cashen, Amanda F.

AU - Epperla, Narendranath

PY - 2019/2

Y1 - 2019/2

N2 - Grade 3A follicular lymphoma (FL) is a heterogenous disease with multiple frontline treatment regimens. We performed a multicenter retrospective analysis to evaluate the efficacy of various frontline regimens for grade 3A FL. Although anthracycline-based therapy was superior to the combination of chemotherapy with cyclophosphamide, vincristine, and prednisone for grade 3A FL, clinical outcomes, including survival, were similar compared to bendamustine-based treatment.

AB - Grade 3A follicular lymphoma (FL) is a heterogenous disease with multiple frontline treatment regimens. We performed a multicenter retrospective analysis to evaluate the efficacy of various frontline regimens for grade 3A FL. Although anthracycline-based therapy was superior to the combination of chemotherapy with cyclophosphamide, vincristine, and prednisone for grade 3A FL, clinical outcomes, including survival, were similar compared to bendamustine-based treatment.

KW - Chemotherapy

KW - Non-Hodgkin lymphoma

UR - http://www.scopus.com/inward/record.url?scp=85058679508&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058679508&partnerID=8YFLogxK

U2 - 10.1016/j.clml.2018.11.010

DO - 10.1016/j.clml.2018.11.010

M3 - Article

C2 - 30581160

AN - SCOPUS:85058679508

SN - 2152-2650

VL - 19

SP - 95

EP - 102

JO - Clinical Lymphoma, Myeloma and Leukemia

JF - Clinical Lymphoma, Myeloma and Leukemia

IS - 2

ER -

Multicenter Analysis of Advanced Stage Grade 3A Follicular Lymphoma Outcomes by Frontline Treatment Regimen

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this